Mustang Bio Inc (MBIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.03
• Market Cap: $7.37M
• EPS: $-6.71
• 52-Week High: $3.68
• 52-Week Low: $0.53

About Mustang Bio Inc

Mustang Bio, Inc. (ticker: MBIO) is a clinical-stage biopharmaceutical company headquartered in Worcester, Massachusetts, focused on pioneering cell and gene therapies for hematologic cancers, solid tumors, and rare genetic disorders. The company boasts a promising pipeline and utilizes advanced technologies aimed at revolutionizing treatment options, striving for potentially curative outcomes for patients. With its strong commitment to innovation in gene editing and strategic collaborations,...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Mustang Bio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MBIO pay dividends?

Mustang Bio Inc (MBIO) does not currently pay a regular dividend.

What is MBIO's market cap?

Mustang Bio Inc (MBIO) has a market capitalization of $7.37M with a current stock price of $1.03.